Current insights into the oncogenic roles of lncRNA LINC00355.
- Published in:
- Cancer Innovation, 2023, v. 2, n. 6, p. 448, doi. 10.1002/cai2.91
- By:
- Publication type:
- Article
Works matching IS 27709183 AND DT 2023 AND VI 2 AND IP 6
Results: 9
1
2
The expression and function of long noncoding RNAs in hepatocellular carcinoma.
- Published in:
- Cancer Innovation, 2023, v. 2, n. 6, p. 488, doi. 10.1002/cai2.90
- By:
- Publication type:
- Article
3
Clinical characteristics of malignant germ cell tumors in adolescents: A multicenter 10‐year retrospective study in Beijing.
- Published in:
- Cancer Innovation, 2023, v. 2, n. 6, p. 524, doi. 10.1002/cai2.87
- By:
- Publication type:
- Article
4
Hepatoblastoma with neonatal necrotizing enterocolitis: Two case reports.
- Published in:
- Cancer Innovation, 2023, v. 2, n. 6, p. 532, doi. 10.1002/cai2.86
- By:
- Publication type:
- Article
5
Mutations in the DNA polymerase binding pathway affect the immune microenvironment of patients with small‐cell lung cancer and enhance the efficacy of platinum‐based chemotherapy.
- Published in:
- Cancer Innovation, 2023, v. 2, n. 6, p. 500, doi. 10.1002/cai2.84
- By:
- Publication type:
- Article
6
Added value of molecular karyotype in childhood acute lymphoblastic leukemia.
- Published in:
- Cancer Innovation, 2023, v. 2, n. 6, p. 513, doi. 10.1002/cai2.67
- By:
- Publication type:
- Article
7
Emerging roles of circular RNAs in the invasion and metastasis of head and neck cancer: Possible functions and mechanisms.
- Published in:
- Cancer Innovation, 2023, v. 2, n. 6, p. 463, doi. 10.1002/cai2.50
- By:
- Publication type:
- Article
8
Issue Information.
- Published in:
- Cancer Innovation, 2023, v. 2, n. 6, p. 1, doi. 10.1002/cai2.18
- Publication type:
- Article
9
Advances in research on molecular markers in immune checkpoint inhibitor‐associated myocarditis.
- Published in:
- Cancer Innovation, 2023, v. 2, n. 6, p. 439, doi. 10.1002/cai2.100
- By:
- Publication type:
- Article